AI assistant
Sending…
LifeMD, Inc. — Director's Dealing 2021
May 19, 2021
33298_dirs_2021-05-19_efcc5676-34b5-440c-90e0-6d3ef9051f34.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LifeMD, Inc. (LFMD)
CIK: 0000948320
Period of Report: 2021-05-19
Reporting Person: Benathen Marc David (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-05-19 | Common Stock | P | 1099 | $8.9334 | Acquired | 16339 | Direct |
| 2021-05-19 | Common Stock | P | 317 | $8.8073 | Acquired | 16656 | Direct |
Footnotes
F1: Jointly held with spouse
F2: The shares beneficially owned have been adjusted to reflect an additional 240 shares not previously reported.
More from LifeMD, Inc.
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Annual Report
2026
Apr 30
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Jan 6
Director's Dealing
2025
Dec 11
Regulatory Filings
2025
Nov 24
Interim / Quarterly Report
2025
Nov 17
Regulatory Filings
2025
Nov 17